|

货币单位:美元(USD)

Ambrx Biopharma, Inc. (amam)

实时(?):

盘后(?):

读取中...

-- (--%)

开盘价:--	最高价:--	最低价:--	52周最高价:--	52周最低价:--
成交量:--	平均成交量:--	市值:--	市盈率:--	预期市盈率:--
每股收益:--	贝塔系数:--	股息:--	收益率:--	总股本:--

提示:交易结束

Sonja Nelson	Sonja Nelson is currently an Independent Director at Motus GI Holdings, Inc. and the Chief Financial Officer at Ambrx, Inc. She also holds the position of Chief Financial Officer at Ambrx Biopharma Cayman, Inc. and Ambrx Biopharma, Inc. Ms. Nelson previously worked as the Director-General Accounting at Cricket Communications, Inc. from 2008 to 2012. She then served as the Senior Director & Controller at Mallinckrodt Hospital Products, Inc. from 2012 to 2014. From 2017 to 2021, Ms. Nelson was a Director at Inex Bio, Inc. She also held the role of Chief Financial Officer at NantKwest, Inc. from 2018 to 2021. Additionally, she worked as the Vice President & Controller at AltheaDx, Inc. from 2014 to 2015. Ms. Nelson has an undergraduate degree from Agnes Scott College and the University of Pforzheim.

Sonja Nelson

Sonja Nelson is currently an Independent Director at Motus GI Holdings, Inc. and the Chief Financial Officer at Ambrx, Inc. She also holds the position of Chief Financial Officer at Ambrx Biopharma Cayman, Inc. and Ambrx Biopharma, Inc. Ms. Nelson previously worked as the Director-General Accounting at Cricket Communications, Inc. from 2008 to 2012. She then served as the Senior Director & Controller at Mallinckrodt Hospital Products, Inc. from 2012 to 2014. From 2017 to 2021, Ms. Nelson was a Director at Inex Bio, Inc. She also held the role of Chief Financial Officer at NantKwest, Inc. from 2018 to 2021. Additionally, she worked as the Vice President & Controller at AltheaDx, Inc. from 2014 to 2015. Ms. Nelson has an undergraduate degree from Agnes Scott College and the University of Pforzheim.